Cargando…

低剂量螺旋CT肺癌筛查研究进展

Lung cancer has become the leading cause of cancer mortality globally, and 5-year survival rate is very poor. Screening and early detection are vital to improve survival and decrease mortality of lung cancer. In recent 20 years, low-dose spiral CT (LDCT) screening has become a research focus in this...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015170/
https://www.ncbi.nlm.nih.gov/pubmed/24113010
http://dx.doi.org/10.3779/j.issn.1009-3419.2013.10.10
_version_ 1783334349410664448
collection PubMed
description Lung cancer has become the leading cause of cancer mortality globally, and 5-year survival rate is very poor. Screening and early detection are vital to improve survival and decrease mortality of lung cancer. In recent 20 years, low-dose spiral CT (LDCT) screening has become a research focus in this area. Randomized controlled trials have confirmed that LDCT can decrease lung cancer mortality. However, there are still some problems of LDCT. In this paper, we summarized the controversy that whether low-dose helical CT screening can reduce lung cancer mortality or not before its effectiveness was been confirmed, the results and problems in the randomized controlled trials and gave a prospect of low-dose helical CT screening's future application.
format Online
Article
Text
id pubmed-6015170
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-60151702018-07-06 低剂量螺旋CT肺癌筛查研究进展 Zhongguo Fei Ai Za Zhi 综述 Lung cancer has become the leading cause of cancer mortality globally, and 5-year survival rate is very poor. Screening and early detection are vital to improve survival and decrease mortality of lung cancer. In recent 20 years, low-dose spiral CT (LDCT) screening has become a research focus in this area. Randomized controlled trials have confirmed that LDCT can decrease lung cancer mortality. However, there are still some problems of LDCT. In this paper, we summarized the controversy that whether low-dose helical CT screening can reduce lung cancer mortality or not before its effectiveness was been confirmed, the results and problems in the randomized controlled trials and gave a prospect of low-dose helical CT screening's future application. 中国肺癌杂志编辑部 2013-10-20 /pmc/articles/PMC6015170/ /pubmed/24113010 http://dx.doi.org/10.3779/j.issn.1009-3419.2013.10.10 Text en 版权所有©《中国肺癌杂志》编辑部2013 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/
spellingShingle 综述
低剂量螺旋CT肺癌筛查研究进展
title 低剂量螺旋CT肺癌筛查研究进展
title_full 低剂量螺旋CT肺癌筛查研究进展
title_fullStr 低剂量螺旋CT肺癌筛查研究进展
title_full_unstemmed 低剂量螺旋CT肺癌筛查研究进展
title_short 低剂量螺旋CT肺癌筛查研究进展
title_sort 低剂量螺旋ct肺癌筛查研究进展
topic 综述
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015170/
https://www.ncbi.nlm.nih.gov/pubmed/24113010
http://dx.doi.org/10.3779/j.issn.1009-3419.2013.10.10